Coffee Consumption and Incident Tachyarrhythmias: Reported Behavior, Mendelian Randomization, and Their Interactions
- PMID: 34279564
- PMCID: PMC8290332
- DOI: 10.1001/jamainternmed.2021.3616
Coffee Consumption and Incident Tachyarrhythmias: Reported Behavior, Mendelian Randomization, and Their Interactions
Erratum in
-
Errors in Table 1, eTable 1, and Figure 2.JAMA Intern Med. 2023 Apr 1;183(4):394. doi: 10.1001/jamainternmed.2022.6962. JAMA Intern Med. 2023. PMID: 36745426 Free PMC article. No abstract available.
Abstract
Importance: The notion that caffeine increases the risk of cardiac arrhythmias is common. However, evidence that the consumption of caffeinated products increases the risk of arrhythmias remains poorly substantiated.
Objective: To assess the association between consumption of common caffeinated products and the risk of arrhythmias.
Design, setting, and participants: This prospective cohort study analyzed longitudinal data from the UK Biobank between January 1, 2006, and December 31, 2018. After exclusion criteria were applied, 386 258 individuals were available for analyses.
Exposures: Daily coffee intake and genetic polymorphisms that affect caffeine metabolism.
Main outcomes and measures: Any cardiac arrhythmia, including atrial fibrillation or flutter, supraventricular tachycardia, ventricular tachycardia, premature atrial complexes, and premature ventricular complexes.
Results: A total of 386 258 individuals (mean [SD] age, 56 [8] years; 52.3% female) were assessed. During a mean (SD) follow-up of 4.5 (3.1) years, 16 979 participants developed an incident arrhythmia. After adjustment for demographic characteristics, comorbid conditions, and lifestyle habits, each additional cup of habitual coffee consumed was associated with a 3% lower risk of incident arrhythmia (hazard ratio [HR], 0.97; 95% CI, 0.96-0.98; P < .001). In analyses of each arrhythmia alone, statistically significant associations exhibiting a similar magnitude were observed for atrial fibrillation and/or flutter (HR, 0.97; 95% CI, 0.96-0.98; P < .001) and supraventricular tachycardia (HR, 0.96; 95% CI, 0.94-0.99; P = .002). Two distinct interaction analyses, one using a caffeine metabolism-related polygenic score of 7 genetic polymorphisms and another restricted to CYP1A2 rs762551 alone, did not reveal any evidence of effect modification. A mendelian randomization study that used these same genetic variants revealed no significant association between underlying propensities to differing caffeine metabolism and the risk of incident arrhythmia.
Conclusions and relevance: In this prospective cohort study, greater amounts of habitual coffee consumption were associated with a lower risk of arrhythmia, with no evidence that genetically mediated caffeine metabolism affected that association. Mendelian randomization failed to provide evidence that caffeine consumption was associated with arrhythmias.
Conflict of interest statement
Figures


Comment in
-
Another Cup of Coffee Without an Arrhythmia, Please.JAMA Intern Med. 2021 Sep 1;181(9):1193-1195. doi: 10.1001/jamainternmed.2021.4073. JAMA Intern Med. 2021. PMID: 34279552 No abstract available.
-
Coffee Consumption and Risk of Adverse Outcomes.JAMA Intern Med. 2022 Jan 1;182(1):94-95. doi: 10.1001/jamainternmed.2021.6920. JAMA Intern Med. 2022. PMID: 34842894 No abstract available.
-
Coffee Consumption and Risk of Adverse Outcomes-Reply.JAMA Intern Med. 2022 Jan 1;182(1):95. doi: 10.1001/jamainternmed.2021.6923. JAMA Intern Med. 2022. PMID: 34842896 No abstract available.
References
-
- Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al; Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2003;108(15):1871-909. doi:10.1161/01.CIR.0000091380.04100.84 - DOI - PubMed
-
- Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. . 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138(13):e272-e391. doi:10.1161/CIR.0000000000000549 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical